Martin Shkreli Quotes


Related Quotes

The “inflated prices” refers to the fact Americans pay more for pharmaceuticals than any other country in the world as the American government allows the companies to charge any amounts while other governments either negotiate or mandate much lower prices.


This quotation is notable as it shows that problems that are not dealt with in one generation can continue for generation after generation. Today we have the exact same problem with overly expensive drugs. In a capitalistic system, every business with good products and sales should make profits. But products that people need to say alive, most people think, should not make larger profit percentages than almost any other business. But this problem is over half a century old in America.


The immediate trigger for this statement was the Mylan Company’s price increase of 500 percent for Epi-pens which people—frequently children—needed to carry to contact a bad allergic reaction that would other wise put them into anaphylactic shock which could be fatal. One of the reasons the company gave for the increase was that their marketing costs were very high. The practice of paying physicians to use a drug and then give testimonials and pitch the drug had long been controversial, but in 2016 the public learned that the practice was much more widespread than anyone had known. Making the situation worse was the fact that physicians would prescribe the drug for their patients and had no obligation to tell the patient or his/her family that he was being paid by the drug company. The Congress held hearings but did nothing at the time.


Martin Shkreli
Martin Shkreli
  • Born: March 17, 1983
  • Nationality: American
  • Profession: Co-founder MSMB Capital Management, Co-founder Former CEO Retrophin, Founder Former CEO Turing Pharmaceuticals

Martin Shkreli, called "Pharma Bro" by some media, is an American former hedge fund manager and convicted felon. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare; the co-founder and former chief executive officer (CEO) of the pharmaceutical firms Retrophin and Turing Pharmaceuticals (now Vyera Pharmaceuticals); and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.